Cell Therapeutics vor Tounaround?
Side effects were significant, with twice as many patients discontinuing for adverse events in the pixantrone arm of the study compared to those taking the treatments on the control arm. 17.6% of the patients who took pixantrone died of side effects related to the drug compared with "only" 7.5% of patients who died from side effects in the control arm.
[/Zitat]
Quelle: http://www.minyanville.com/businessmarkets/...010/id/26767?from=yahoo